Timothy Coughlin - 30 May 2024 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role
Director
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Issuer symbol
ATYR
Transactions as of
30 May 2024
Net transactions value
+$87,500
Form type
4
Filing time
03 Jun 2024, 16:21:12 UTC
Previous filing
23 May 2024
Next filing
11 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $87,500 +50,000 +833% $1.75 56,000 30 May 2024 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.665 to $1.80 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006.